FRIDAY, Dec. 13, 2024 (HealthDay News) -- For patients with ductal carcinoma in situ (DCIS), active monitoring (AM) is ...
A new study published in the New England Journal of Medicine examines whether removing lymph nodes is always necessary in early breast cancer.
Researchers examined pooled data from two clinical trials that enrolled patients with low- or intermediate-grade ductal ...
A “watch-and-wait” strategy might be the best option for some women with early-stage, low-risk breast cancer.According ...
For patients with “good-risk” ductal carcinoma in situ (DCIS) who underwent breast- conserving surgery and did not receive radiotherapy, tamoxifen significantly decreased the risk of recurrence in the ...